Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Bio Green Med Solution, Inc. (BGMS) vs Ernexa Therapeutics Inc. (ERNA)

Bio Green Med Solution, Inc. and Ernexa Therapeutics Inc. are both Biotechnology companies. Bio Green Med Solution, Inc. and Ernexa Therapeutics Inc. are of similar size ($6.2M and $5.9M). Bio Green Med Solution, Inc. grew revenue faster over the last twelve months: 2,414.9% against −78.6%. Ernexa Therapeutics Inc. has the higher net margin (0.00% vs −715.5%) and the higher return on invested capital (0.00% vs −67.3%). Across the 17 metrics below, Bio Green Med Solution, Inc. leads on 10 and Ernexa Therapeutics Inc. on 7.

Valuation

Metric BGMS ERNA Biotechnology median
P/E n/m n/m 7.88
P/S 2.77 7.01 11.47
P/B 0.72 1.28 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 0.73 55.39 10.73
Earnings yield (395.65%) (415.94%) (28.84%)
Free cash flow yield (19.45%) (217.53%) (23.03%)

Profitability

Metric BGMS ERNA Biotechnology median
Gross margin 19.34% 83.51% 65.16%
Operating margin (194.95%) 0.00% 0.00%
Net margin (715.48%) 0.00% 0.00%
Free cash flow margin (59.00%) 0.00% 0.00%
Return on equity (246.85%) (321.22%) (57.72%)
Return on assets (217.30%) (176.62%) (49.22%)
Return on invested capital (67.28%) 0.00% 0.00%

Growth

Metric BGMS ERNA Biotechnology median
Revenue growth (TTM) 2,414.86% (78.60%) 5.64%
EPS growth (last fiscal year) 98.71% 95.42% —
Revenue growth, 5-year CAGR (17.41%) (50.61%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BGMS ERNA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.63 2.01 4.73
Net debt to EBITDA 0.42 0.21 0.96

Dividend

Metric BGMS ERNA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BGMS ERNA Biotechnology median
Market cap 6.16m 5.91m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack